Protective effects of 15-methy-lipoxin A4 on mesangioproliferative nephritis in rats

Chinese Journal of Contemporary Pediatrics

Volumn 8, Issue 3, 2006, Pages 225-230

  Wu, Sheng Hua ^a   Liao, Pei Yuan ^a   Dong, Ling ^a   Jiang, Xin You ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin; Lipoxin; Mesangial cells; Nephritis; Nuclear factor B; Rats

Indexed keywords

15 METHYLLIPOXIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXIN A; MESSENGER RNA; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; RADIOIMMUNOASSAY; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DNA; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; INTERLEUKIN-1; INTERLEUKIN-6; LIPOXINS; NF-KAPPA B; RATS; RATS, INBRED LEW; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 33745648312     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kieran NE, Maderna P, Godson C. Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease[J]. Kidney Int, 2004, 65(4): 1145-1154.
2. Mitchell D, Rodgers K, Hanly J, McMahon B, Brady HR, Martin F, et al. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells[J]. Am J Pathol, 2000, 164 (3): 937-946.
3. 4 in human renal mesangial cells[J]. J Biol Chem, 2000, 275(36): 27566-27575.
4. 4 inhibits TNF-α-induced production of interleukins and proliferation of rat mesangial cells[J]. Kidney Int, 2005, 68(1): 35-46.
5. Wu SH, Kelefiotis DP, Lianos EA. Modulatory effects of eicosanoids on mesangial cell growth in response to immune injury [J]. Immunopharmacology, 1994, 28(2): 125-136.
6. Bresnahan BA, Wu SH, Fenov FJ, Roman RJ, Lianos EA. Mesangial cell immune injury: hemodynamic role of leukocyte- and platelet-derived eicosanoids[J]. J Clin Invest, 1992, 90(6): 2304-2312.
7. Chinese source. 2004,6(3):195-198.
8. Chinese source. 1992,12(3):133-138.
9. Yamamoto T, Wilson CB. Quantitative and qualitative studies of anti-body-induced mesangial cell damage in the rat[J]. Kidney Int, 1987, 32(4): 514-525.
10. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichil RH, Gordon KL, et al. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis [J]. Kidney Int, 1996, 50(4): 1230-1239.
11. 4, is protective in experimental ischemic renal failure[J]. J Am Soc Nephrol, 2002, 13(6): 1657-1662.
12. Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, Sasaki S. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-κB and Bad[J]. J Am Soc Nephrol, 2003, 14(6): 1427-1434.